S. Katikireddi
The Lancet · 2002–2024
A researcher in the Science corpus: 21 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from S. Katikireddi's perspective
Ordered by how strongly the researchers S. Katikireddi trusts endorse each paper. Same corpus, a different order for every researcher.
- A simple method for converting an odds ratio to effect size for use in meta-analysis.
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (Ca)
- Depression and anxiety in patients with cancer (British medical journal)
- Self-Management: Enabling and empowering patients living with cancer as a chronic illness (Ca)
- Psychosocial Interventions for Depression, Anxiety, and Quality of Life in Cancer Survivors: Meta-Analyses (International Journal of Psychiatry in Medicine)
- GRADE guidelines: 3. Rating the quality of evidence. (Journal of Clinical Epidemiology)
- Unemployment impairs mental health: Meta-analyses
- GRADE guidelines 6. Rating the quality of evidence--imprecision. (Journal of Clinical Epidemiology)
- Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies (Journal of cancer survivorship)
- Synthesizing and presenting findings using other methods (Cochrane Handbook for Systematic Reviews of Interventions)
Their papers
- The GRADE Working Group clarifies the construct of certainty of evidence (2017) — 611 citations
- Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline (2020) — 3,632 citations
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) — 2,896 citations
- Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2024) — 1,610 citations
- Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 (2024) — 644 citations
- Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study (2021) — 605 citations
- Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 (2021) — 1,685 citations
- Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 (2021) — 991 citations
- Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019 (2020) — 838 citations
- Mitigating the wider health effects of covid-19 pandemic response (2020) — 908 citations
- Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 (2020) — 5,916 citations
- Depression and anxiety among people living with and beyond cancer: a growing clinical and research priority (2019) — 638 citations
- Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) — 2,198 citations
- Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. (2018) — 844 citations
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 (2018) — 8,401 citations
- GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence. (2018) — 718 citations
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years. (2017) — 2,261 citations
- Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) — 4,276 citations
- Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) — 632 citations
- Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017) — 2,211 citations